{"title":"Tobacco Use Disorder and Co-Occurring Mental Health Conditions: Considerations for Future DSM.","authors":"Megan M Kelly, Maria Karekla, Jaimee L Heffner","doi":"10.1097/NMD.0000000000001877","DOIUrl":"10.1097/NMD.0000000000001877","url":null,"abstract":"<p><p>There is a significantly higher prevalence of tobacco use disorder (TUD) among individuals with mental health conditions, and they account for nearly 40% of cigarettes smoked in the United States. Although the DSM-5 notes the high prevalence of co-occurring mental health conditions with TUD and that nicotine withdrawal symptoms mimic the symptoms of other mental health conditions such as anxiety, depressive, and bipolar disorders, the discussion of co-occurring mental health conditions in relation to TUD is limited. DSM-6 presents an important opportunity to expand diagnostic guidance, recognize shared and bidirectional etiological mechanisms, and recommend systematic screening and intervention approaches for TUD in the context of mental health treatment. Expanded guidance for differential diagnosis and treatment in DSM-6 could promote tobacco cessation as an essential component of mental health care, thereby improving clinical outcomes for people with TUD and co-occurring mental health conditions.</p>","PeriodicalId":16480,"journal":{"name":"Journal of Nervous and Mental Disease","volume":"214 5","pages":"94-96"},"PeriodicalIF":1.5,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149075106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mesut Sari, Yasemin İmrek, Güler Göl Özcan, Yusuf Öztürk, Gonca Özyurt, Kadir Özdel, Ali Evren Tufan
{"title":"Emotional and Early Maladaptive Schemas in Adolescents Diagnosed With Major Depressive Disorder.","authors":"Mesut Sari, Yasemin İmrek, Güler Göl Özcan, Yusuf Öztürk, Gonca Özyurt, Kadir Özdel, Ali Evren Tufan","doi":"10.1097/NMD.0000000000001886","DOIUrl":"https://doi.org/10.1097/NMD.0000000000001886","url":null,"abstract":"<p><strong>Aim: </strong>Early maladaptive schemas and dysfunctional emotional schema beliefs are implicated in adolescent major depressive disorder; however, their relationship with comorbid anxiety disorders remains unclear.</p><p><strong>Methods: </strong>In this cross-sectional controlled cohort study, 87 adolescents diagnosed with major depressive disorder according to Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition criteria and 100 healthy controls completed the Young Schema Questionnaire-Short Form 3, the Leahy Emotional Schema Scale, the Beck Depression Inventory, and the Screen for Child Anxiety Related Emotional Disorders. Hierarchical regression analyses examined predictors of depressive symptom severity.</p><p><strong>Results: </strong>Adolescents with major depressive disorder demonstrated significantly higher early maladaptive schema and emotional schema scores than controls. Comorbid anxiety disorders were associated with greater schema pathology. In hierarchical regression analyses, LESS-II total score emerged as the strongest independent correlate of depressive symptom severity.</p><p><strong>Conclusions: </strong>Schema-related dysfunction is prominent in adolescent depression, particularly when anxiety is present.</p>","PeriodicalId":16480,"journal":{"name":"Journal of Nervous and Mental Disease","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148818354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Traumatic Experiences and Obsessive-Compulsive Symptoms the Mediating Role of Dissociation: Erratum.","authors":"Gianluca Santoro, Lucia Sideli, Fanny Guglielmucci, Grazia Terrone, Adriano Schimmenti","doi":"10.1097/NMD.0000000000001878","DOIUrl":"10.1097/NMD.0000000000001878","url":null,"abstract":"","PeriodicalId":16480,"journal":{"name":"Journal of Nervous and Mental Disease","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148456172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Response to the Correspondence on \"Risk of Schizophrenia After a Diagnosis of Epilepsy\".","authors":"Seung Won Lee, Hohyun Jung, Youngoh Bae","doi":"10.1097/NMD.0000000000001879","DOIUrl":"10.1097/NMD.0000000000001879","url":null,"abstract":"","PeriodicalId":16480,"journal":{"name":"Journal of Nervous and Mental Disease","volume":"214 4","pages":"71-73"},"PeriodicalIF":1.5,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148604230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Felix Inchausti, Nancy V García-Poveda, Alejandro Ballesteros-Prados, Eduardo Fonseca-Pedrero, Angus MacBeth, Raffaele Popolo, Giancarlo Dimaggio
{"title":"Metacognitive Interpersonal Group Therapy for Adolescents With Personality Disorders: Results From the METAMIND-A Pilot Randomized Controlled Trial.","authors":"Felix Inchausti, Nancy V García-Poveda, Alejandro Ballesteros-Prados, Eduardo Fonseca-Pedrero, Angus MacBeth, Raffaele Popolo, Giancarlo Dimaggio","doi":"10.1097/NMD.0000000000001869","DOIUrl":"10.1097/NMD.0000000000001869","url":null,"abstract":"<p><strong>Aim: </strong>This pilot RCT evaluated the feasibility, acceptability, and preliminary effects of Metacognitive Interpersonal Group Therapy for Adolescents (MIT-GA) compared with waiting list plus treatment-as-usual (WL+TAU).</p><p><strong>Methods: </strong>One hundred adolescents (14-18 years) meeting DSM-IV criteria for PDs (excluding antisocial PD) were randomized to MIT-GA or WL+TAU for 4 months. Primary outcomes included treatment acceptability, psychosocial functioning (CGAS, IIP-64), and symptom severity (SCL-90-R GSI). Secondary outcomes were depression (Y-BDI), caregiver stress (PSS), and parental self-efficacy (BPSES). Mechanisms of change included metacognition (MAS-A), alexithymia (TAS-20), and impulsivity (BIS-11).</p><p><strong>Results: </strong>MIT-GA participants showed greater improvements in psychosocial functioning ( d = 0.80) and parental stress ( d = 0.65) versus WL+TAU. No significant between-group differences were found in overall symptom severity. MIT-GA also improved metacognition, alexithymia, and attentional impulsivity. No adverse events were reported.</p><p><strong>Conclusions: </strong>These findings support the feasibility and potential utility of MIT-GA for adolescents with PDs.</p>","PeriodicalId":16480,"journal":{"name":"Journal of Nervous and Mental Disease","volume":" ","pages":"74-80"},"PeriodicalIF":1.5,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147377908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Karim Abdel Aziz, Inês d'Almeida, Martin M Schumacher, Josef Finsterer, João Gama-Marques
{"title":"Reconsidering the Association Between Epilepsy and Schizophrenia: Diagnostic Misclassification of Epilepsy-related Psychoses.","authors":"Karim Abdel Aziz, Inês d'Almeida, Martin M Schumacher, Josef Finsterer, João Gama-Marques","doi":"10.1097/NMD.0000000000001875","DOIUrl":"https://doi.org/10.1097/NMD.0000000000001875","url":null,"abstract":"","PeriodicalId":16480,"journal":{"name":"Journal of Nervous and Mental Disease","volume":"214 4","pages":"69-70"},"PeriodicalIF":1.5,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148604225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Efficacy and Safety of Aripiprazole in Children and Adolescents With Autism Spectrum Disorder: A Meta-Analysis.","authors":"Şenay Kılınçel, Furkan Bulut, Oğuzhan Kılınçel","doi":"10.1097/NMD.0000000000001874","DOIUrl":"10.1097/NMD.0000000000001874","url":null,"abstract":"<p><strong>Aim: </strong>Aripiprazole is one of the few pharmacological agents approved for managing irritability in children and adolescents with autism spectrum disorder (ASD).</p><p><strong>Methods: </strong>Randomized controlled trials comparing oral aripiprazole with placebo or active drugs in participants under 18 years were systematically searched in major databases through September 2025 (last search: September 15, 2025). The primary outcome was change in Aberrant Behavior Checklist-Irritability (ABC-I) scores; data were synthesized using random-effects models.</p><p><strong>Results: </strong>Eleven trials ( N = 1,135) were included. Aripiprazole significantly reduced irritability (mean difference = -5.18; 95% CI = -6.72 to -3.64; I 2 = 0%) and improved global ratings versus placebo. Common adverse effects were weight gain, sedation, and extrapyramidal symptoms, though discontinuation rates were comparable to placebo.</p><p><strong>Conclusions: </strong>Aripiprazole effectively and safely reduces irritability in pediatric ASD. Although adverse effects are frequent, they are generally manageable, supporting individualized dosing and long-term monitoring.</p>","PeriodicalId":16480,"journal":{"name":"Journal of Nervous and Mental Disease","volume":" ","pages":"81-88"},"PeriodicalIF":1.5,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13405634/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147972954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Activation Syndrome in Patients Diagnosed With Major Depressive Disorder for the First Time: The Role of Past Hypomania Symptoms and Atypical Depression as Risk Factors.","authors":"Onur Gökçen, Kader Semra Karataş, Merve Akkuş, Feyza Dönmez, Mete Arslan Konak","doi":"10.1097/NMD.0000000000001871","DOIUrl":"10.1097/NMD.0000000000001871","url":null,"abstract":"<p><strong>Aim: </strong>Activation syndrome, a possible consequence of antidepressant treatment, has been linked to suicidal ideation, yet its definition remains debated. This study investigated the frequency and risk factors of activation syndrome in patients with first-episode major depressive disorder.</p><p><strong>Methods: </strong>Two hundred six patients were assessed at baseline, week 2, and week 4. Baseline measures included the Hypomania-Checklist-32, the Temperament Evaluation of Memphis, Pisa, Paris, and San Diego-autoquestionnaire, and evaluations of anxious distress, mixed features, and atypical depression. Follow-up interviews assessed activation syndrome.</p><p><strong>Results: </strong>Activation Syndrome occurred in 33% ( n = 68). It was associated with younger age, atypical depression, higher Hypomania-Checklist-32 scores, anxious distress, cyclothymic/irritable temperaments, and suicidal ideation. Logistic regression showed past hypomania and atypical depression as significant predictors. Associations remained after excluding mania/hypomania cases.</p><p><strong>Conclusions: </strong>In first-episode major depressive disorder, past hypomania symptoms and atypical depression increase activation syndrome risk, highlighting the need for close monitoring given implications for bipolarity and suicidality.</p>","PeriodicalId":16480,"journal":{"name":"Journal of Nervous and Mental Disease","volume":" ","pages":"59-67"},"PeriodicalIF":1.5,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147377936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Separation, Trauma, and Developmental Cost: The Mental Health Effects of Immigration Enforcement on Children.","authors":"Yael Dvir","doi":"10.1097/NMD.0000000000001873","DOIUrl":"10.1097/NMD.0000000000001873","url":null,"abstract":"","PeriodicalId":16480,"journal":{"name":"Journal of Nervous and Mental Disease","volume":"214 3","pages":"45-46"},"PeriodicalIF":1.5,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148471197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Should We Adjust for Baseline Covariates in Randomized Clinical Trials?","authors":"Ralitza Gueorguieva","doi":"10.1097/NMD.0000000000001876","DOIUrl":"10.1097/NMD.0000000000001876","url":null,"abstract":"<p><strong>Introduction: </strong>The primary goal in randomized clinical trials (RCTs) is to estimate the causal effects of interventions. Since prognostic factors can also affect outcomes, RCTs often employ covariate-adjusted analyses. It is important to review reasons for adjustment, advantages and disadvantages of adjustments, and reiterate best practices.</p><p><strong>Methods: </strong>We reviewed guidelines and recommendations for covariate adjustment from authoritative sources, including the European Medicines Agency and the US Food and Drug Administration, as well as recent studies and meta-analyses.</p><p><strong>Results: </strong>While post hoc adjustments for baseline covariates may lead to bias, unadjusted analyses and prespecified adjusted analyses are valid approaches for RCTs. Adjustment for highly prognostic variables can enhance precision and power. Direct adjustment methods and more complex methods, such as inverse probability of treatment weighting, can be applied.</p><p><strong>Conclusions: </strong>Covariate adjustments should be prespecified, theoretically justified, and transparently reported. This approach aligns with the CONSORT 2025 guidelines, emphasizing methodological rigor and transparency.</p>","PeriodicalId":16480,"journal":{"name":"Journal of Nervous and Mental Disease","volume":"214 3","pages":"43-44"},"PeriodicalIF":1.5,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148471143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}